Filter posts

Updated Legal and Regulatory Frameworks Needed for Biosimilars

Biosimilars raise novel and complex questions of science and law that require updated legal and …

Attacks on Venture Philanthropy Miss Mark Badly

In a highly problematic op-ed in today’s New York Times, freelance journalist Llewellyn Hinkes-Jones attacked venture philanthropy …

Wall Street Journal Highlights Promising Gene Therapy Advances

Yesterday, bluebird bio reported some very uplifting news at the annual meeting of the American …

San Francisco Chronicle: High Drug Co-Pays Deny Needed Treatments

Today, the San Francisco Chronicle published an op-ed that I wrote on the importance of …

Welcome to San Diego!

Welcome to the 2014 BIO International Convention. It has been an exciting and important year …

BIO and Biominas Brasil to Co-Host 2014 BIO Latin America Conference

I am excited to announce that BIO will co-host a new conference event, BIO Latin …

Biotech Investors, Emerging Companies Bullish On 2014

The 16th BIO CEO & Investor Conference is off to a great start. This event …

Stable Policy Can Help Assure Unwavering Investment in U.S. Biofuels

The Renewable Fuel Standard (RFS) is a unique federal policy that has, just as its …

Ask CA Governor Brown To Sign SB 598

California’s Assembly and Senate have both overwhelmingly passed Senate Bill 598, legislation that creates a …

State Legislation Needed For Substitution of Interchangeable Biologics

A great deal of the media coverage relating to California’s Senate Bill 598  neglects to …